FDA Approves First Drug for Treatment of Peanut Allergy in Children
The US Food and Drug Administration has approved the first drug to treat life-threatening peanut allergies in children.
The new drug — AR101, or Palforzia — does not provide a cure for allergy sufferers, but it helps increase their tolerance to small quantities of peanuts and decrease the risk of a reaction to accidental exposure, according to USA Today.
Palforzia, which was approved for use in patients between ages 4 and 17, comes in the form of a powder that is sprinkled on food. It will will carry a list price of $890 per month.
Raed More at New York Post
